SIL1 and Ataxia: While substantial clinical heterogeneity exists among patients diagnostically labelled as MSS, mutations in the SIL1 gene on chromosome 5q seem to result in a relatively homogeneous phenotype, characterised by congenital cataracts, developmental delay, severe ataxia and cerebellar atrophy, and chronic myopathy [12,13].